Medivir
More than 25 years of experience in cancer research. During the last 10 years focused on industrial drug discovery and development projects in oncology. Prior to that he managed an academic research group as principal investigator, and has initiated several innovative scientific projects in cancer biology. He has published more than 50 scientific articles and holds several patents. Adjunct professor at the Medical Faculty of Uppsala University.
This person is not in any offices
Medivir
Medivir is a Swedish biotech company. It focuses its research on oncology and particularly on innovative pharmaceuticals that meet substantial unmet medical needs.